Stuglik Brian M
SEC CIK 1716328 · EDGAR
BoughtSold
Most active insiders at PBYI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | AUERBACH ALAN H | Pres, CEO, Dir, 10% | — | $568.9K |
| 2 | Cesano Alessandra | Dir | — | $567.0K |
| 3 | Senderowicz Adrian | Dir | — | $194.3K |
| 4 | MOYES JAY M | Dir | — | $158.8K |
| 5 | NOUGUES MAXIMO F | CFO | — | $141.7K |
| 6 | WILSON TROY EDWARD | Dir | — | $123.2K |
| 7 | HUNT DOUGLAS M | See Remarks | — | $122.6K |
| 8 | MILLER MICHAEL PATRICK | Dir | — | $97.2K |
| 9 | Dorval Allison | Dir | — | $83.6K |
| 10 | Stuglik Brian M | Dir | — | $58.3K |
Transactions 39
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-15 20:14 | 2026-06-11 | PBYI | PUMA BIOTECHNOLOGY, INC. | Stuglik Brian M | Dir | A - Grant | $0.00 | +27.0K | 122.0K | +28% | $0 |
| T | 2026-06-15 20:14 | 2026-06-12 | PBYI | PUMA BIOTECHNOLOGY, INC. | Stuglik Brian M | Dir | S - Sale | $7.20 | -8,100 | 113.9K | -7% | -$58.3K |
| 2026-05-26 18:22 | 2026-05-21 | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | A - Grant | $0.00 | +36.0K | 137.1K | +36% | $0 | |
| 2025-12-18 | 2025-12-16 | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | S - Sale | $9.14 | -592 | 101.1K | -0.6% | -$5,411 | |
| 2025-09-18 | 2025-09-16 | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | S - Sale | $9.99 | -587 | 101.7K | -0.6% | -$5,864 | |
| 2025-06-20 | 2025-06-16 | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | S - Sale | $5.65 | -594 | 102.3K | -0.6% | -$3,356 | |
| 2025-06-17 | 2025-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | Stuglik Brian M | Dir | S - Sale | $3.39 | -8,100 | 95.0K | -8% | -$27.5K | |
| 2025-06-13 | 2025-06-11 | PBYI | PUMA BIOTECHNOLOGY, INC. | Stuglik Brian M | Dir | A - Grant | $0.00 | +27.0K | 103.1K | +35% | $0 | |
| D | 2025-05-27 | 2025-05-22 | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | A - Grant | $0.00 | +8,333 | 102.9K | +9% | $0 |
| 2025-03-19 | 2025-03-17 | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | S - Sale | $6.95 | -593 | 94.6K | -0.6% | -$4,121 | |
| M | 2024-12-20 | 2024-12-16+ | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | S - Sale | $4.48 | -929 | 95.2K | -1.0% | -$4,161 |
| 2024-09-20 | 2024-09-19 | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | S - Sale | $2.79 | -336 | 96.1K | -0.3% | -$937.44 | |
| 2024-09-18 | 2024-09-16 | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | S - Sale | $2.80 | -600 | 96.4K | -0.6% | -$1,680 | |
| 2024-06-21 | 2024-06-18 | PBYI | PUMA BIOTECHNOLOGY, INC. | Stuglik Brian M | Dir | A - Grant | $0.00 | +27.0K | 76.1K | +55% | $0 | |
| DM | 2024-06-20 | 2024-06-17+ | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | S - Sale | $3.39 | -928 | 97.0K | -0.9% | -$3,145 |
| D | 2024-06-20 | 2024-06-18 | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | A - Grant | $0.00 | +8,333 | 97.4K | +9% | $0 |
| 2024-06-17 | 2024-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | Stuglik Brian M | Dir | S - Sale | $3.39 | -9,900 | 49.1K | -17% | -$33.6K | |
| M | 2024-03-20 | 2024-03-18+ | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | S - Sale | $10.60 | -810 | 89.9K | -0.9% | -$8,585 |
| M | 2023-12-20 | 2023-12-18+ | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | S - Sale | $7.67 | -761 | 90.5K | -0.8% | -$5,839 |
| M | 2023-09-20 | 2023-09-18+ | VSTM | Verastem, Inc. | Stuglik Brian M | Dir | S - Sale | $9.88 | -752 | 91.2K | -0.8% | -$7,433 |
| M | 2023-06-21 | 2023-06-16+ | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | S - Sale | $10.06 | -762 | 92.0K | -0.8% | -$7,664 |
| 2023-06-15 | 2023-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | Stuglik Brian M | Dir | S - Sale | $3.46 | -9,900 | 32.0K | -24% | -$34.3K | |
| 2023-06-15 | 2023-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | Stuglik Brian M | Dir | A - Grant | $0.00 | +27.0K | 59.0K | +84% | $0 | |
| M | 2023-03-20 | 2023-03-16+ | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | S - Sale | $0.4108 | -9,784 | 1.12M | -0.9% | -$4,019 |
| M | 2022-12-20 | 2022-12-16+ | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | S - Sale | $0.3963 | -28.7K | 1.12M | -2% | -$11.4K |
| 2022-09-21 | 2022-09-19 | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | S - Sale | $1.13 | -3,355 | 1.15M | -0.3% | -$3,791 | |
| 2022-08-02 | 2022-08-01 | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | S - Sale | $1.08 | -5,858 | 1.15M | -0.5% | -$6,327 | |
| 2022-06-22 | 2022-06-21 | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | S - Sale | $1.14 | -3,362 | 1.16M | -0.3% | -$3,833 | |
| 2022-06-21 | 2022-06-16 | PBYI | PUMA BIOTECHNOLOGY, INC. | Stuglik Brian M | Dir | S - Sale | $2.69 | -13.0K | 41.9K | -24% | -$35.0K | |
| 2022-06-16 | 2022-06-14 | PBYI | PUMA BIOTECHNOLOGY, INC. | Stuglik Brian M | Dir | A - Grant | $0.00 | +27.0K | 54.9K | +97% | $0 | |
| 2022-05-17 | 2022-05-16 | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | S - Sale | $1.03 | -13.8K | 1.16M | -1% | -$14.2K | |
| 2022-05-17 | 2022-05-14 | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | A - Grant | $0.00 | +50.0K | 1.18M | +4% | $0 | |
| 2022-05-04 | 2022-05-02 | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | S - Sale | $1.41 | -5,857 | 1.13M | -0.5% | -$8,258 | |
| 2022-03-23 | 2022-03-21 | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | S - Sale | $1.27 | -3,507 | 1.13M | -0.3% | -$4,454 | |
| 2022-02-02 | 2022-01-31 | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | S - Sale | $1.48 | -5,695 | 1.14M | -0.5% | -$8,429 | |
| 2022-01-05 | 2022-01-03 | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | S - Sale | $2.05 | -26.0K | 1.14M | -2% | -$53.4K | |
| 2021-12-22 | 2021-12-20 | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | S - Sale | $2.27 | -13.7K | 1.17M | -1% | -$31.1K | |
| D | 2021-12-17 | 2021-11-01 | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | F - Tax | $2.59 | -5,839 | 819.4K | -0.7% | -$15.1K |
| D | 2021-12-17 | 2021-12-15 | VSTM | Verastem, Inc. | Stuglik Brian M | CEO, Dir | A - Grant | $0.00 | +363.0K | 1.18M | +44% | $0 |
Purchase Sale Sale after option exercise All abbreviations